SCHEMBL30837883

SCHEMBL30837883

COc1ccc(Cn2c(=O)c3cc(C)ccc3n(C3CCN(C=O)CC3)c2=O)cc1OC

nearest known ligand 0.76

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
PDE7A Q13946 10/20 0.76
PDE7B Q9NP56 5/20 0.73
PDE8A O60658 3/20 0.73
LMNA P02545 4/20 0.44
TSHR P16473 4/20 0.44
HTT P42858 4/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
ALDH1A1 P00352 1/20 0.44
TP53 P04637 2/20 0.42
RXFP1 Q9HBX9 1/20 0.41
C5AR1 P21730 1/20 0.41
GAA P10253 1/20 0.40
MAPK1 P28482 1/20 0.40
SIGMAR1 Q99720 1/20 0.40
KDM4E B2RXH2 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL100675 1.00 PDE7A (0.76) PDE7APDE7BPDE8ALMNATSHR
SCHEMBL100010 0.95 PDE7A (0.75) PDE7APDE7BPDE8ALMNATSHR
SCHEMBL10320444 0.91 PDE7A (0.76) PDE7APDE7BPDE8ALMNATSHR
SCHEMBL99714 0.90 PDE7A (0.76) PDE7APDE7BPDE8ALMNATSHR
SCHEMBL100713 0.88 PDE7A (0.83) PDE7APDE7BPDE8ALMNATSHR
SCHEMBL30837862 0.88 PDE7A (0.73) PDE7APDE7BPDE8ALMNATSHR
SCHEMBL100653 0.88 PDE7A (0.73) PDE7APDE7BPDE8ALMNATSHR
SCHEMBL30837831 0.88 PDE7A (0.83) PDE7APDE7BPDE8ALMNATSHR
SCHEMBL7878461 0.87 PDE7A (0.82) PDE7APDE7BPDE8ALMNATSHR
SCHEMBL30837897 0.87 PDE7A (0.86) PDE7APDE7BPDE8ALMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4572765-A1 USE OF A THERAPEUTIC AGENT WITH PHOSPHODIESTERASE-7 INHIBITORY ACTIVITY FOR THE TREATMENT AND PREVENTION OF DISEASES ASSOCIATED WITH CHRONIC FATIGUE, EXHAUSTION AND/OR EXERTIONAL INTOLERANCE Mitodicure GmbH (DE) 2025-06-25 EP disclosed
WO-2024038089-A1 USE OF A THERAPEUTIC AGENT WITH PHOSPHODIESTERASE-7 INHIBITORY ACTIVITY FOR THE TREATMENT AND PREVENTION OF DISEASES ASSOCIATED WITH CHRONIC FATIGUE, EXHAUSTION AND/OR EXERTIONAL INTOLERANCE MITODICURE GMBH (DE) 2024-02-22 WO disclosed